Fidson Healthcare Plc Share Price

Equities

FIDSON

NGFIDSON0006

Pharmaceuticals

End-of-day quote Nigerian S.E. 23:00:00 25/04/2024 BST 5-day change 1st Jan Change
14.35 NGN 0.00% Intraday chart for Fidson Healthcare Plc -9.75% -18.00%

Financials

Sales 2022 40.63B 30.56M 2.45B Sales 2023 53.05B 39.89M 3.19B Capitalization 40.16B 30.2M 2.42B
Net income 2022 4.19B 3.15M 252M Net income 2023 3.61B 2.71M 217M EV / Sales 2022 0.82 x
Net Debt 2022 12.78B 9.61M 769M Net Debt 2023 17.77B 13.36M 1.07B EV / Sales 2023 1.09 x
P/E ratio 2022
4.93 x
P/E ratio 2023
11.1 x
Employees 650
Yield 2022
6.11%
Yield 2023
3.43%
Free-Float 78.29%
More Fundamentals * Assessed data
Dynamic Chart
Fidson Healthcare Plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Fidson Healthcare Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Fidson Healthcare Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Fidson Healthcare Plc Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Fidson Healthcare Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Fidson Healthcare Plc Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Fidson Healthcare Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Fidson Healthcare Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Fidson Healthcare plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Fidson Healthcare Plc Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Fidson Healthcare Plc Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Fidson Healthcare Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Fidson Healthcare Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Fidson Healthcare plc Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Fidson Healthcare Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
More news
1 week-9.75%
Current month-7.42%
1 month-7.42%
3 months-18.93%
6 months-4.27%
Current year-18.00%
More quotes
1 week
14.35
Extreme 14.35
15.90
1 month
14.35
Extreme 14.35
15.90
Current year
13.65
Extreme 13.65
19.20
1 year
9.05
Extreme 9.05
19.20
3 years
4.18
Extreme 4.1818
19.20
5 years
2.01
Extreme 2.0091
19.20
10 years
0.81
Extreme 0.8091
19.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/12/94
Director of Finance/CFO - -
Director/Board Member - 31/12/20
Members of the board TitleAgeSince
Chairman - 31/12/17
Chief Executive Officer - 31/12/94
Director/Board Member - 31/12/00
More insiders
Date Price Change Volume
26/04/24 14.35 0.00% 17,066
25/04/24 14.35 0.00% 267,969
24/04/24 14.35 -9.75% 126,311
23/04/24 15.9 0.00% 8,325
22/04/24 15.9 0.00% 210,643

End-of-day quote Nigerian S.E., April 25, 2024

More quotes
Fidson Healthcare specializes in developing, manufacturing and marketing pharmaceutical products for the treatment of infectious, inflammatory, endocrinal, gastrointestinal, immune, metabolic, cardiovascular, oncological and central nervous system disorders. Net sales break down by activity as follows: - sale of prescription medicines (70.7%) ; - sale of OTC products (29.3%).
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.35 NGN
Average target price
22.47 NGN
Spread / Average Target
+56.59%
Consensus

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. FIDSON Stock